Detalhe da pesquisa
1.
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Cancer Immunol Immunother
; 70(2): 519-531, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852603
2.
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
Br J Cancer
; 122(4): 564-568, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844183